In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progression and tau spreading, yet the mechanisms underlying faster disease manifestation are unknown. To address this, we combined resting-state fMRI and longitudinal tau-PET in two independent samples of controls and biomarker-confirmed AD patients (ADNI/BioFINDER, n = 240/57). Consistent across both samples, we found that younger symptomatic AD patients showed stronger tau-PET in globally connected fronto-parietal hubs, i.e., regions that are critical for maintaining cognition in AD. Stronger tau-PET in hubs predicted faster subsequent tau accumulation, suggesting that tau in globally connected regions facilitates connectivity-mediated tau spreading...
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Tau pathology and neuroinflammation are key etio-pathogenetic mediators of Alzheimer’s disease (AD)....
See Whitwell (doi:10.1093/brain/awy001) for a scientific commentary on this article.A stereotypical ...
In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progressio...
Background: In Alzheimer’s disease (AD), younger symptom onset is associated accelerated cognitive d...
In Alzheimer's diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Background: The clinical features of Alzheimer's disease (AD) vary substantially depending on whethe...
In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the cerebral cor...
BACKGROUND: Combining PET amyloid-β (Aβ) and tau imaging may be critical for tracking disease progr...
Tau PET enables in vivo visualization and quantitation of tau accumulation in Alzheimer disease (AD)...
In Alzheimer's diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Alzheimer’s Disease Neuroimaging Initiative.Alzheimer’s disease (AD) is characterized by the spread ...
Amyloid-beta is thought to facilitate the spread of tau throughout the neocortex in Alzheimer's dise...
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Tau pathology and neuroinflammation are key etio-pathogenetic mediators of Alzheimer’s disease (AD)....
See Whitwell (doi:10.1093/brain/awy001) for a scientific commentary on this article.A stereotypical ...
In Alzheimer’s disease (AD), younger symptom onset is associated with accelerated disease progressio...
Background: In Alzheimer’s disease (AD), younger symptom onset is associated accelerated cognitive d...
In Alzheimer's diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Background: The clinical features of Alzheimer's disease (AD) vary substantially depending on whethe...
In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Alzheimer’s disease (AD) is characterized by the spread of tau pathology throughout the cerebral cor...
BACKGROUND: Combining PET amyloid-β (Aβ) and tau imaging may be critical for tracking disease progr...
Tau PET enables in vivo visualization and quantitation of tau accumulation in Alzheimer disease (AD)...
In Alzheimer's diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinic...
Advances in molecular positron emission tomography (PET) have enabled anatomic tracking of brain pat...
Alzheimer’s Disease Neuroimaging Initiative.Alzheimer’s disease (AD) is characterized by the spread ...
Amyloid-beta is thought to facilitate the spread of tau throughout the neocortex in Alzheimer's dise...
A new piece to the puzzle:Contributions of in vivo Tau to Neurodegeneration in Alzheimer’s DiseaseGé...
Tau pathology and neuroinflammation are key etio-pathogenetic mediators of Alzheimer’s disease (AD)....
See Whitwell (doi:10.1093/brain/awy001) for a scientific commentary on this article.A stereotypical ...